The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials.
Liu Z, Chen Y, Jie C, Wang J, Deng Y, Hou X, Li Y, Cai W.
Front Endocrinol (Lausanne). 2023 Apr 3;14:1144290. doi: 10.3389/fendo.2023.1144290. eCollection 2023.
PMID:37077355
Pupillary responses in non-proliferative diabetic retinopathy.
Park JC, Chen YF, Blair NP, Chau FY, Lim JI, Leiderman YI, Shahidi M, McAnany JJ.
Sci Rep. 2017 Mar 23;7:44987. doi: 10.1038/srep44987.
PMID:28332564
Effect of Chinese Patent Medicines on Ocular Fundus Signs and Vision in Calcium Dobesilate-Treated Persons With Non-Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Zhang Y, An X, Duan L, Jin D, Duan Y, Zhou R, Zhang Y, Kang X, Lian F.
Front Endocrinol (Lausanne). 2022 Mar 14;13:799337. doi: 10.3389/fendo.2022.799337. eCollection 2022.
PMID:35370950
Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N, Waugh N.
Health Technol Assess. 2015 Jul;19(51):v-xxviii, 1-247. doi: 10.3310/hta19510.
PMID:26173799
Automatic non-proliferative diabetic retinopathy screening system based on color fundus image.